These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

878 related articles for article (PubMed ID: 32421155)

  • 41. Audio Interview: Vaccinology and Covid-19.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 Oct; 383(16):e109. PubMed ID: 33053301
    [No Abstract]   [Full Text] [Related]  

  • 42. Anticipating Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Testing, Licensure, and Recommendations for Use.
    Edwards KM; Orenstein WA
    J Pediatr; 2020 Sep; 224():124-128. PubMed ID: 32565096
    [No Abstract]   [Full Text] [Related]  

  • 43. Riding the coronacoaster of uncertainty.
    The Lancet Infectious Diseases
    Lancet Infect Dis; 2020 Jun; 20(6):629. PubMed ID: 32422202
    [No Abstract]   [Full Text] [Related]  

  • 44. Global governance for COVID-19 vaccines.
    The Lancet
    Lancet; 2020 Jun; 395(10241):1883. PubMed ID: 32563355
    [No Abstract]   [Full Text] [Related]  

  • 45. Exploit T cell Immunity for Rapid, Safe and Effective COVID-19 Vaccines.
    Moise L; Ross TM; Hoft DF; Martin WD; De Groot AS
    Expert Rev Vaccines; 2020 Sep; 19(9):781-784. PubMed ID: 32962468
    [No Abstract]   [Full Text] [Related]  

  • 46. News Feature: Avoiding pitfalls in the pursuit of a COVID-19 vaccine.
    Peeples L
    Proc Natl Acad Sci U S A; 2020 Apr; 117(15):8218-8221. PubMed ID: 32229574
    [No Abstract]   [Full Text] [Related]  

  • 47. COVID-19 vaccines: no time for complacency.
    The Lancet
    Lancet; 2020 Nov; 396(10263):1607. PubMed ID: 33220729
    [No Abstract]   [Full Text] [Related]  

  • 48. Of Viruses, Vaccines, and Variability: Qualitative Meaning Matters.
    Reyna VF
    Trends Cogn Sci; 2020 Sep; 24(9):672-675. PubMed ID: 32600966
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Up Is Down - Pharmaceutical Industry Caution vs. Federal Acceleration of Covid-19 Vaccine Approval.
    Avorn J; Kesselheim AS
    N Engl J Med; 2020 Oct; 383(18):1706-1708. PubMed ID: 32931162
    [No Abstract]   [Full Text] [Related]  

  • 50. Patient-reported outcomes: central to the management of COVID-19.
    Aiyegbusi OL; Calvert MJ
    Lancet; 2020 Aug; 396(10250):531. PubMed ID: 32791038
    [No Abstract]   [Full Text] [Related]  

  • 51. The Regulation of COVID-19 "Challenge" Studies.
    Menikoff J
    Am J Bioeth; 2020 Jul; 20(7):80-82. PubMed ID: 32716768
    [No Abstract]   [Full Text] [Related]  

  • 52. Talk to Patients About: Why Will It Take So Long for a COVID-19 Vaccine?
    Price S
    Tex Med; 2020 Jun; 116(6):19. PubMed ID: 32645183
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Not Available].
    Nau JY
    Rev Med Suisse; 2020 Jun; 16(696):1176-1177. PubMed ID: 32496711
    [No Abstract]   [Full Text] [Related]  

  • 54. The arrival of Sputnik V.
    Balakrishnan VS
    Lancet Infect Dis; 2020 Oct; 20(10):1128. PubMed ID: 32979327
    [No Abstract]   [Full Text] [Related]  

  • 55. Tracking a Vaccine and Developing Therapeutics for COVID-19.
    Gould KA
    Dimens Crit Care Nurs; 2020; 39(6):293-297. PubMed ID: 33009266
    [No Abstract]   [Full Text] [Related]  

  • 56. Developing Covid-19 Vaccines at Pandemic Speed.
    Lurie N; Saville M; Hatchett R; Halton J
    N Engl J Med; 2020 May; 382(21):1969-1973. PubMed ID: 32227757
    [No Abstract]   [Full Text] [Related]  

  • 57. Ensuring global access to COVID-19 vaccines.
    Yamey G; Schäferhoff M; Hatchett R; Pate M; Zhao F; McDade KK
    Lancet; 2020 May; 395(10234):1405-1406. PubMed ID: 32243778
    [No Abstract]   [Full Text] [Related]  

  • 58. Developing a SARS-CoV-2 Vaccine at Warp Speed.
    O'Callaghan KP; Blatz AM; Offit PA
    JAMA; 2020 Aug; 324(5):437-438. PubMed ID: 32628244
    [No Abstract]   [Full Text] [Related]  

  • 59. Developing Safe and Effective Covid Vaccines - Operation Warp Speed's Strategy and Approach.
    Slaoui M; Hepburn M
    N Engl J Med; 2020 Oct; 383(18):1701-1703. PubMed ID: 32846056
    [No Abstract]   [Full Text] [Related]  

  • 60. Preparing the public for COVID-19 vaccines: How can general practitioners build vaccine confidence and optimise uptake for themselves and their patients?
    Danchin M; Biezen R; Manski-Nankervis JA; Kaufman J; Leask J
    Aust J Gen Pract; 2020 Oct; 49(10):625-629. PubMed ID: 33015676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.